🇺🇸 FDA
Patent

US 8501912

Filipil compositions and methods for treating cancer

granted A61KA61K35/13A61K38/1709

Quick answer

US patent 8501912 (Filipil compositions and methods for treating cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/13, A61K38/1709, A61K48/00, A61P